Technology Opportunities

Refine / Revise Search3 technologies found
page 1 of 1
Novel Therapeutic Target and Diagnostic Marker for Asthma and Related Conditions (CD48) (Yissum)
Anti-CD48 agent blocks CD48 stimulatory pathway and inhibits the activity and expression of CD48 Categories Drugs, Allergic airway inflammations, Asthma Development Stage Laboratory and animal trials were performed Patent Status Patent pending Market Size The invention is ...
Scientific Contact: Francesca Levi-Schaffer
More Details...
Research & Services | a model for testing non immunogenic urticaria (Yissum)
Additional material on the technology can be supplied upon ...
Scientific Contact: Francesca Levi-Schaffer
More Details...
Research & Services | Allergy and Immunopharmacology Laboratory (Yissum)
Categories Allergies, immunopharmacology of inflammation Objective/function The laboratory is active in the field of allergy and immunopharmacology of inflammation Research provided In vitro tests on human mast cells and on human eosinophils on the inhibitory activity of potential ...
Scientific Contact: Francesca Levi-Schaffer
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.